Literature DB >> 2388040

Protein kinase regulates tumor necrosis factor mRNA stability in virus-stimulated astrocytes.

A P Lieberman1, P M Pitha, M L Shin.   

Abstract

Infection of astrocytes with Newcastle disease virus stimulated the production of 1,2-diacylglycerol, and resulted in the kinase-dependent expression of mRNAs encoding tumor necrosis factor (TNF), interferon alpha and beta, and interleukin 6. The half-life of TNF mRNA was significantly decreased in the presence of protein kinase inhibitors H-7 and staurosporine, but not in the presence of HA1004. In contrast to the decay of TNF mRNA, the half-lives of other cytokine mRNAs were only minimally affected by the kinase inhibitors. These data indicated that the stability of TNF mRNA was regulated through a novel, kinase-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2388040      PMCID: PMC2188550          DOI: 10.1084/jem.172.3.989

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Autoregulated instability of beta-tubulin mRNAs by recognition of the nascent amino terminus of beta-tubulin.

Authors:  T J Yen; P S Machlin; D W Cleveland
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

2.  Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes.

Authors:  D S Robbins; Y Shirazi; B E Drysdale; A Lieberman; H S Shin; M L Shin
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

3.  Two levels of regulation of beta-interferon gene expression in human cells.

Authors:  N B Raj; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

4.  Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus.

Authors:  A P Lieberman; P M Pitha; H S Shin; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway.

Authors:  T Lindstein; C H June; J A Ledbetter; G Stella; C B Thompson
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

6.  Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation.

Authors:  B Thorens; J J Mermod; P Vassalli
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

7.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

Authors:  H Hidaka; M Inagaki; S Kawamoto; Y Sasaki
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

8.  Kinetic analysis of 1,2-diacylglycerol mass levels in cultured fibroblasts. Comparison of stimulation by alpha-thrombin and epidermal growth factor.

Authors:  T M Wright; L A Rangan; H S Shin; D M Raben
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

9.  Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation.

Authors:  J L Casey; M W Hentze; D M Koeller; S W Caughman; T A Rouault; R D Klausner; J B Harford
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

10.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

View more
  10 in total

1.  The 3' untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR.

Authors:  J L Dean; R Wait; K R Mahtani; G Sully; A R Clark; J Saklatvala
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Importance of post-transcriptional regulation of chemokine genes by oxidative stress.

Authors:  C Josse; J R Boelaert; M Best-Belpomme; J Piette
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

3.  Genomic and cDNA sequence analysis of the cell matrix adhesion regulator gene.

Authors:  H Durbin; M R Novelli; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays.

Authors:  Stefanie Galbán; Jinshui Fan; Jennifer L Martindale; Chris Cheadle; Bryan Hoffman; Michael P Woods; Gretchen Temeles; Jürgen Brieger; Jochen Decker; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

5.  Removal of a 3' non-coding sequence is an initial step in degradation of gro alpha mRNA and is regulated by interleukin-1.

Authors:  M Y Stoeckle
Journal:  Nucleic Acids Res       Date:  1992-03-11       Impact factor: 16.971

6.  Binding of a protein to an AU-rich domain of tumour necrosis factor alpha mRNA as a 35 kDa complex and its regulation in primary rat astrocytes.

Authors:  Y U Kim; H G Rus; S N Fisher; P M Pitha; M L Shin
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

7.  UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription.

Authors:  Muhammad M Bashir; Meena R Sharma; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2008-11-13       Impact factor: 8.551

8.  Stimulation of tumor necrosis factor alpha production in human monocytes by inhibitors of protein phosphatase 1 and 2A.

Authors:  S J Sung; J A Walters; S M Fu
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

9.  Regulation of cytokine production in the human thymus: epidermal growth factor and transforming growth factor alpha regulate mRNA levels of interleukin 1 alpha (IL-1 alpha), IL-1 beta, and IL-6 in human thymic epithelial cells at a post-transcriptional level.

Authors:  P T Le; S Lazorick; L P Whichard; B F Haynes; K H Singer
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

Review 10.  Glial-mediated inflammation underlying parkinsonism.

Authors:  Carlos Barcia
Journal:  Scientifica (Cairo)       Date:  2013-07-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.